Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.

Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
复制标题

2015 年冠状动脉疾病最新突破性试验：评论涵盖 ACC、EuroPCR、SCAI、TCT、ESC 和 AHA。

DOI：
10.1002/ccd.26474
复制
发表时间：
2016
期刊：
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
影响因子：
--
通讯作者：
Tremmel,JenniferA
Tremmel,JenniferA
中科院分区：
--
文献类型：
--
作者：
Seto,ArnoldH;JordanSafirstein;Anwaruddin,Saif;Dehghani,Payam;Shah,Binita;Tremmel,JenniferA

文献摘要

相似文献

SCAI出版委员会和新兴领导指导（ELM）研究员简要总结并提供了2015年大型国际会议上提出的最重要的冠状动脉试验的背景，包括MATRIX、吸收和TOTAL试验。其目的是为了将试验结果快速纳入介入治疗实践，并使忙碌的介入心脏病专家能够及时了解最新情况。©2016 Wiley期刊公司
The SCAI Publications Committee and Emerging Leadership Mentorship (ELM) Fellows concisely summarize and provide context on the most important coronary trials presented at large international meetings in 2015, including the MATRIX, ABSORB, and TOTAL trials. The intent is to allow quick assimilation of trial results into interventional practice, and enable busy interventional cardiologists to stay up to date. © 2016 Wiley Periodicals, Inc.